Evolysse Launch Success
Evolysse exceeded internal expectations with $9.7 million in revenue, marking the strongest first-quarter filler launch in over a decade. The product received positive feedback and achieved strong early adoption.
International Expansion
Evolus expanded its global footprint to nine markets, representing over 70% of its international total addressable market, and remains on track to achieve $100 million in international revenue by 2028.
Consumer Loyalty Program Performance
Evolus Rewards redemptions hit a record high of over 224,000, with 65% coming from repeat patients, indicating strong brand loyalty and consumer satisfaction.
Market Share Growth
Jeuveau maintained a 14% market share in the first half of the year, reflecting an increase over the full year 2024 share of 13%, despite market challenges.